Related Experiment Video
Updated: May 10, 2026

Combination of High Ligation and Intraoperative Embolization Using Polidocanol for Treatment of Varicoceles
Published on: December 22, 2023
[Treatment of superficial infantile hemangiomas with topical propranolol]
Jing-Ning Niu1, Guang-Qi Xu, Ren-Rong Lü
1Department of Aesthetic, Plastic, and Burn Surgery, Shandong Provincial Hospital, Jinan 250021, China.
Insights
Topical 1% propranolol ointment effectively treated superficial infantile hemangiomas (IHs) in 87.8% of cases with no systemic side effects. This offers a safe treatment option for IHs.
Area of Science:
- Dermatology
- Pediatrics
- Pharmacology
Context:
- Infantile hemangiomas (IHs) are common benign vascular tumors in infants.
- Superficial IHs can cause cosmetic concerns and potential complications.
- Current treatment options have limitations, necessitating exploration of new therapeutic strategies.
Purpose:
- To assess the efficacy and safety of 1% propranolol ointment for superficial infantile hemangiomas.
- To evaluate treatment response based on changes in size, texture, and color.
- To identify any adverse effects associated with topical propranolol therapy.
Summary:
- A retrospective review of 49 children with 58 superficial IHs treated with 1% propranolol ointment.
- Treatment involved thrice-daily application for a mean of 21.1 weeks.
- Good or partial response was observed in 87.8% of cases, with no systemic complications.
Impact:
- 1% propranolol ointment demonstrates significant efficacy in treating superficial IHs.
- Topical propranolol is a safe adjuvant therapy during the 'wait-and-see' period for IHs.
- This treatment offers a promising, non-invasive approach for managing infantile hemangiomas.
Objective:
To evaluate the efficacy and safety of 1% propranolol ointment in the treatment of superficial infantile hemangiomas (IHs).
Methods:
A retrospective chart review was performed on 49 children (34 female and 15 male) with a median age of 4.1 months (range, 1-10 months). A total of 58 superficial IHs were treated with 1% propranolol ointment. Topical propranolol was applied three times daily for a mean duration of 21.1 weeks (range, 5-59 weeks). Changes in the size, texture, and color of the tumor were monitored and recorded at regular intervals. The treatment response was evaluated using a 3-point scale system: good, partial, and no response. Adverse effects after medication were evaluated and managed accordingly.
Results:
Of the 49 cases, 26 (53.1%) demonstrated good response, 17 (34.7%) showed a partial response, and 6 (12.2%) had no response. The total effective rate was 87.8% . No systemic complication was observed in any of the patients.
Conclusions:
Topical therapy with 1% propranolol ointment may be a safe and effective method for the treatment of superficial IHs and can be used as an adjuvant treatment measure during the wait-and-see period.
Related Concept Videos
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Antihypertensive Drugs: Vasodilators
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
